VANCOUVER, British Columbia, March 18, 2016 — Effective March 4, 2016 Northern Lipids Inc. changed its corporate name to TRANSFERRA Nanosciences Inc. The formerly named Northern Lipids Inc., has been operating for 25 years as a contract research company in Vancouver, providing a number of services and products in the life science sector.
Don Enns, President and CEO of TRANSFERRA explained, “This new name more accurately reflects the business services and products the company now offers to organizations commercializing pharmaceutical candidates.”
TRANSFERRA’s corporate objectives are to serve the needs of companies actively developing lipid nanoparticle drug delivery systems. They work with virtually all classes of pharmaceuticals, from small molecules to peptides, proteins, DNA, mRNA, siRNA and antisense. The TRANSFERRA team has made significant contributions to current practices and underlying concepts associated with the formulation of lipid nanoparticle-based pharmaceuticals.
About TRANSFERRA Nanosciences Inc.
TRANSFERRA is a Contract Development and Manufacturing Organization (CDMO) that provides products and services to biotechnology companies engaged in the development of pharmaceutical products.